Charles Albright
2020
In 2020, Charles Albright earned a total compensation of $2M as Former Executive Vice President and Chief Scientific Officer at Editas Medicine, a 3% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,249,956 |
|---|---|
| Salary | $466,385 |
| Stock Awards | $325,184 |
| Other | $8,056 |
| Total | $2,049,581 |
Albright received $1.2M in option awards, accounting for 61% of the total pay in 2020.
Albright also received $466.4K in salary, $325.2K in stock awards and $8.1K in other compensation.
Rankings
In 2020, Charles Albright's compensation ranked 5,390th out of 13,090 executives tracked by ExecPay. In other words, Albright earned more than 58.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,390 out of 13,090 | 59th |
Division Manufacturing | 2,221 out of 5,621 | 61st |
Major group Chemicals And Allied Products | 887 out of 2,254 | 61st |
Industry group Drugs | 765 out of 1,954 | 61st |
Industry Biological Products, Except Diagnostic Substances | 182 out of 411 | 56th |
Pay ratio
| Charles Albright's Pay | $2,049,581 |
|---|---|
| Median Employee's Pay | $162,706 |
| Pay Ratio | 13to 1 |
In 2020, the annual total compensation of Charles Albright was $2,049,581.
The annual total compensation of the median employee at Editas Medicine was $162,706.
The ratio of Charles Albright's pay to the pay of median employee was therefore 13 to one.
Source: SEC filing on April 20, 2021.
Albright's colleagues
We found five more compensation records of executives who worked with Charles Albright at Editas Medicine in 2020.